Global Acute Heart Failure (AHF) Therapeutics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 16-Jul-2021
No. of pages: 95
Inquire Before Buying

Market Analysis and Insights: Global Acute Heart Failure (AHF) Therapeutics Market

The global Acute Heart Failure (AHF) Therapeutics market size is projected to reach US$ 1398 million by 2027, from US$ 262.2 million in 2020, at a CAGR of 26.8% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Heart Failure (AHF) Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Heart Failure (AHF) Therapeutics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Heart Failure (AHF) Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Heart Failure (AHF) Therapeutics market.

Global Acute Heart Failure (AHF) Therapeutics Scope and Market Size

Acute Heart Failure (AHF) Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Heart Failure (AHF) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- B-Blockers

- Calcium Channel Blockers

- Cardiac Glycosides

- Diuretics

- Morphine

- Vasodilators/Nitrates

- Others

Segment by Application

- Hospital

- Clinic

- Home Care

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Bayer AG

- Bristol-Myers Squibb Company

- Cardiorentis AG

- CVie Therapeutics Limited

- Cytokinetics, Inc.

- Merck & Co.

- Novartis AG

- Orion Corporation

- PhaseBio Pharmaceuticals, Inc

Global Acute Heart Failure (AHF) Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Heart Failure (AHF) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 B-Blockers
1.2.3 Calcium Channel Blockers
1.2.4 Cardiac Glycosides
1.2.5 Diuretics
1.2.6 Morphine
1.2.7 Vasodilators/Nitrates
1.2.8 Others
1.3 Market by Application
1.3.1 Global Acute Heart Failure (AHF) Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Acute Heart Failure (AHF) Therapeutics Market Perspective (2016-2027)
2.2 Acute Heart Failure (AHF) Therapeutics Growth Trends by Regions
2.2.1 Acute Heart Failure (AHF) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Heart Failure (AHF) Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Acute Heart Failure (AHF) Therapeutics Industry Dynamic
2.3.1 Acute Heart Failure (AHF) Therapeutics Market Trends
2.3.2 Acute Heart Failure (AHF) Therapeutics Market Drivers
2.3.3 Acute Heart Failure (AHF) Therapeutics Market Challenges
2.3.4 Acute Heart Failure (AHF) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Heart Failure (AHF) Therapeutics Players by Revenue
3.1.1 Global Top Acute Heart Failure (AHF) Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Acute Heart Failure (AHF) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Heart Failure (AHF) Therapeutics Revenue
3.4 Global Acute Heart Failure (AHF) Therapeutics Market Concentration Ratio
3.4.1 Global Acute Heart Failure (AHF) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Heart Failure (AHF) Therapeutics Revenue in 2020
3.5 Acute Heart Failure (AHF) Therapeutics Key Players Head office and Area Served
3.6 Key Players Acute Heart Failure (AHF) Therapeutics Product Solution and Service
3.7 Date of Enter into Acute Heart Failure (AHF) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Heart Failure (AHF) Therapeutics Breakdown Data by Type
4.1 Global Acute Heart Failure (AHF) Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Type (2022-2027)
5 Acute Heart Failure (AHF) Therapeutics Breakdown Data by Application
5.1 Global Acute Heart Failure (AHF) Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Acute Heart Failure (AHF) Therapeutics Market Size (2016-2027)
6.2 North America Acute Heart Failure (AHF) Therapeutics Market Size by Type
6.2.1 North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2027)
6.3 North America Acute Heart Failure (AHF) Therapeutics Market Size by Application
6.3.1 North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2027)
6.4 North America Acute Heart Failure (AHF) Therapeutics Market Size by Country
6.4.1 North America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Acute Heart Failure (AHF) Therapeutics Market Size (2016-2027)
7.2 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type
7.2.1 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2027)
7.3 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application
7.3.1 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2027)
7.4 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Country
7.4.1 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Application
8.3.1 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Acute Heart Failure (AHF) Therapeutics Market Size (2016-2027)
9.2 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Type
9.2.1 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Application
9.3.1 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Country
9.4.1 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Application
10.3.1 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Acute Heart Failure (AHF) Therapeutics Introduction
11.1.4 Bayer AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Cardiorentis AG
11.3.1 Cardiorentis AG Company Details
11.3.2 Cardiorentis AG Business Overview
11.3.3 Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Introduction
11.3.4 Cardiorentis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.3.5 Cardiorentis AG Recent Development
11.4 CVie Therapeutics Limited
11.4.1 CVie Therapeutics Limited Company Details
11.4.2 CVie Therapeutics Limited Business Overview
11.4.3 CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Introduction
11.4.4 CVie Therapeutics Limited Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.4.5 CVie Therapeutics Limited Recent Development
11.5 Cytokinetics, Inc.
11.5.1 Cytokinetics, Inc. Company Details
11.5.2 Cytokinetics, Inc. Business Overview
11.5.3 Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Introduction
11.5.4 Cytokinetics, Inc. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.5.5 Cytokinetics, Inc. Recent Development
11.6 Merck & Co.
11.6.1 Merck & Co. Company Details
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Acute Heart Failure (AHF) Therapeutics Introduction
11.6.4 Merck & Co. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.6.5 Merck & Co. Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Acute Heart Failure (AHF) Therapeutics Introduction
11.7.4 Novartis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.7.5 Novartis AG Recent Development
11.8 Orion Corporation
11.8.1 Orion Corporation Company Details
11.8.2 Orion Corporation Business Overview
11.8.3 Orion Corporation Acute Heart Failure (AHF) Therapeutics Introduction
11.8.4 Orion Corporation Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.8.5 Orion Corporation Recent Development
11.9 PhaseBio Pharmaceuticals, Inc
11.9.1 PhaseBio Pharmaceuticals, Inc Company Details
11.9.2 PhaseBio Pharmaceuticals, Inc Business Overview
11.9.3 PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Introduction
11.9.4 PhaseBio Pharmaceuticals, Inc Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.9.5 PhaseBio Pharmaceuticals, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Acute Heart Failure (AHF) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of B-Blockers
Table 3. Key Players of Calcium Channel Blockers
Table 4. Key Players of Cardiac Glycosides
Table 5. Key Players of Diuretics
Table 6. Key Players of Morphine
Table 7. Key Players of Vasodilators/Nitrates
Table 8. Key Players of Others
Table 9. Global Acute Heart Failure (AHF) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Acute Heart Failure (AHF) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Acute Heart Failure (AHF) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Acute Heart Failure (AHF) Therapeutics Market Share by Regions (2016-2021)
Table 13. Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Acute Heart Failure (AHF) Therapeutics Market Share by Regions (2022-2027)
Table 15. Acute Heart Failure (AHF) Therapeutics Market Trends
Table 16. Acute Heart Failure (AHF) Therapeutics Market Drivers
Table 17. Acute Heart Failure (AHF) Therapeutics Market Challenges
Table 18. Acute Heart Failure (AHF) Therapeutics Market Restraints
Table 19. Global Acute Heart Failure (AHF) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Acute Heart Failure (AHF) Therapeutics Market Share by Players (2016-2021)
Table 21. Global Top Acute Heart Failure (AHF) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Heart Failure (AHF) Therapeutics as of 2020)
Table 22. Ranking of Global Top Acute Heart Failure (AHF) Therapeutics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Acute Heart Failure (AHF) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Acute Heart Failure (AHF) Therapeutics Product Solution and Service
Table 26. Date of Enter into Acute Heart Failure (AHF) Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Type (2016-2021)
Table 30. Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Acute Heart Failure (AHF) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Application (2016-2021)
Table 34. Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Bayer AG Company Details
Table 67. Bayer AG Business Overview
Table 68. Bayer AG Acute Heart Failure (AHF) Therapeutics Product
Table 69. Bayer AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Bayer AG Recent Development
Table 71. Bristol-Myers Squibb Company Company Details
Table 72. Bristol-Myers Squibb Company Business Overview
Table 73. Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Product
Table 74. Bristol-Myers Squibb Company Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Bristol-Myers Squibb Company Recent Development
Table 76. Cardiorentis AG Company Details
Table 77. Cardiorentis AG Business Overview
Table 78. Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Product
Table 79. Cardiorentis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Cardiorentis AG Recent Development
Table 81. CVie Therapeutics Limited Company Details
Table 82. CVie Therapeutics Limited Business Overview
Table 83. CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Product
Table 84. CVie Therapeutics Limited Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 85. CVie Therapeutics Limited Recent Development
Table 86. Cytokinetics, Inc. Company Details
Table 87. Cytokinetics, Inc. Business Overview
Table 88. Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Product
Table 89. Cytokinetics, Inc. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Cytokinetics, Inc. Recent Development
Table 91. Merck & Co. Company Details
Table 92. Merck & Co. Business Overview
Table 93. Merck & Co. Acute Heart Failure (AHF) Therapeutics Product
Table 94. Merck & Co. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Merck & Co. Recent Development
Table 96. Novartis AG Company Details
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Acute Heart Failure (AHF) Therapeutics Product
Table 99. Novartis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Novartis AG Recent Development
Table 101. Orion Corporation Company Details
Table 102. Orion Corporation Business Overview
Table 103. Orion Corporation Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Orion Corporation Recent Development
Table 105. PhaseBio Pharmaceuticals, Inc Company Details
Table 106. PhaseBio Pharmaceuticals, Inc Business Overview
Table 107. PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Product
Table 108. PhaseBio Pharmaceuticals, Inc Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 109. PhaseBio Pharmaceuticals, Inc Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Heart Failure (AHF) Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. B-Blockers Features
Figure 3. Calcium Channel Blockers Features
Figure 4. Cardiac Glycosides Features
Figure 5. Diuretics Features
Figure 6. Morphine Features
Figure 7. Vasodilators/Nitrates Features
Figure 8. Others Features
Figure 9. Global Acute Heart Failure (AHF) Therapeutics Market Share by Application: 2020 VS 2027
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Home Care Case Studies
Figure 13. Acute Heart Failure (AHF) Therapeutics Report Years Considered
Figure 14. Global Acute Heart Failure (AHF) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Acute Heart Failure (AHF) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Acute Heart Failure (AHF) Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Acute Heart Failure (AHF) Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Acute Heart Failure (AHF) Therapeutics Market Share by Players in 2020
Figure 19. Global Top Acute Heart Failure (AHF) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Heart Failure (AHF) Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Acute Heart Failure (AHF) Therapeutics Revenue in 2020
Figure 21. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Acute Heart Failure (AHF) Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Acute Heart Failure (AHF) Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Acute Heart Failure (AHF) Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Acute Heart Failure (AHF) Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Acute Heart Failure (AHF) Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Acute Heart Failure (AHF) Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Share by Region (2016-2027)
Figure 43. China Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Acute Heart Failure (AHF) Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Acute Heart Failure (AHF) Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Acute Heart Failure (AHF) Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Bayer AG Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 63. Bristol-Myers Squibb Company Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 64. Cardiorentis AG Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 65. CVie Therapeutics Limited Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 66. Cytokinetics, Inc. Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 67. Merck & Co. Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 68. Novartis AG Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 69. Orion Corporation Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 70. PhaseBio Pharmaceuticals, Inc Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
  • Global Ceiling Lifts Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 146
    A ceiling lift is a motorized device that lifts and transfers a person from point to point along an overhead track. The track can be ceiling mounted, or may be portable (self-standing or free-standing track). The device incorporates a sling for the person being transferred. Market Analysis and Insights: Global Ceiling Lifts Market The global Ceiling Lifts market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 20......
  • Global Medical Metal Implants Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 145
    An implant is a device used to help replace a biological structure that has been damaged due to trauma or bone and cartilage disorders. Metall implant materials have gained immense clinical importance in the medical field for a long time. Many of metal and metal alloys which were used for medical requirements include stainless steel (316L), titanium and alloys (Cp-Ti, Ti6Al4V), cobalt-chromium alloys (Co-Cr), aluminum alloys, zirconium-niobium, and tungsten heavy alloys. Market An......
  • Global Simply Lancet Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 147
    Simply lancet is a small medical implement used for capillary blood sampling. A simply lancet is similar to a small scalpel but with a double-edged blade or needle. Lancets are used to make punctures, such as a fingerstick, to obtain small blood specimens. Simply lancets are generally disposable. Market Analysis and Insights: Global Simply Lancet Market The global Simply Lancet market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at ......
  • Global Depth of Anesthesia Monitoring Devices Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 139
    Market Analysis and Insights: Global Depth of Anesthesia Monitoring Devices Market The global Depth of Anesthesia Monitoring Devices market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Depth of Anesthesia Monitoring Devices Scope and Market Size The global Depth of Anesthesia Monitoring Devices market is segmented by company, region (country), by Type, and by Application. Players, sta......
  • Global TLSO Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 143
    Market Analysis and Insights: Global TLSO Market The global TLSO market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global TLSO Scope and Market Size The global TLSO market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global TLSO market will be able to gain the upper hand as they use the report as a powerful res......
  • Global Thorax Lumbus Sacrum Orthosis Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 148
    Market Analysis and Insights: Global Thorax Lumbus Sacrum Orthosis Market The global Thorax Lumbus Sacrum Orthosis market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Thorax Lumbus Sacrum Orthosis Scope and Market Size The global Thorax Lumbus Sacrum Orthosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in......
  • Global Modular Automation Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 131
    Market Analysis and Insights: Global Modular Automation Market The global Modular Automation market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Modular Automation Scope and Market Size The global Modular Automation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Modular Automation market will b......
  • Global Task Targeted Automation Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 131
    Market Analysis and Insights: Global Task Targeted Automation Market The global Task Targeted Automation market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Task Targeted Automation Scope and Market Size The global Task Targeted Automation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Task Tar......
  • Global Total Lab Automation System Sales Market Report 2021
    Published: 23-Jul-2021        Price: US 4000 Onwards        Pages: 139
    Market Analysis and Insights: Global Total Lab Automation System Market The global Total Lab Automation System market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Total Lab Automation System Scope and Market Size The global Total Lab Automation System market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the glo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs